Rise in Early-Onset Cancers: More Diagnoses, Not Always More Disease

Rise in Early-Onset Cancers: More Diagnoses, Not Always More Disease

Not every detected cancer is clinically meaningful. For younger patients, especially, this can mean confronting a diagnosis that may never…

Dr. Theodore W. Laetsch, Synovial Sarcoma Foundation Board Member, Receives $1 Million Grant to Advance Rare Tumor Studies

Dr. Theodore W. Laetsch, Synovial Sarcoma Foundation Board Member, Receives $1 Million Grant to Advance Rare Tumor Studies

The Synovial Sarcoma Foundation is pleased to highlight a significant milestone at the Children’s Hospital of Philadelphia (CHOP), where pediatric…

Innovative Approach Shows Promise Against Synovial Sarcoma Using Protein-Blocking Drugs

Innovative Approach Shows Promise Against Synovial Sarcoma Using Protein-Blocking Drugs

The Synovial Sarcoma Foundation is dedicated to supporting cutting-edge research that advances treatment options for this rare and aggressive cancer.…

New Market Insights Highlight Growth in Synovial Sarcoma Treatments

New Market Insights Highlight Growth in Synovial Sarcoma Treatments

The Synovial Sarcoma Foundation is committed to staying informed on the latest research and developments in this rare and aggressive…

Tumor Board Continues to Grow with New Members to Advance Breakthrough Treatments for Synovial Sarcoma Patients

Tumor Board Continues to Grow with New Members to Advance Breakthrough Treatments for Synovial Sarcoma Patients

We are proud to share that the Tumor Board now includes 42 participating institutions, strengthening our collective expertise and reach.…

Synovial Sarcoma Foundation Celebrates Groundbreaking Achievement by Rachel Dr. Hurly

Synovial Sarcoma Foundation Celebrates Groundbreaking Achievement by Rachel Dr. Hurly

The Synovial Sarcoma Foundation is proud to announce a significant milestone in pediatric cancer research: Dr. Rachel Hurly, a dedicated…

Callan Spence: Survivor. Driver. Relentless Advocate.

Callan Spence: Survivor. Driver. Relentless Advocate.

Callan Spence isn’t waiting for progress—he’s chasing it down at full speed. At 20 years old, Callan is already a…

Inaugural Synovial Sarcoma Conference

Inaugural Synovial Sarcoma Conference

On March 1, CHOP, in collaboration with Penn Medicine and the Synovial Sarcoma Foundation, hosted the first-ever national virtual conference…

The Latest Synovial Sarcoma Data

A Global Survey for

Doctors Researchers Patients Advocates

Understanding the experiences of Synovial Sarcoma patients is essential to identifying challenges, improving treatment, and advancing research. Access comprehensive survey results by joining our Facebook Group, where you can connect with others in the community.

A data table displaying survey results for synovial sarcoma, including patient gender, age, location, primary tumor site, year diagnosed, tumor size, metastasis status, chemotherapy, radiation, surgery, NED duration, and recurrence location.